miRagen Therapeutics's Director of Biology to Give Keynote Lecture at The Ohio State University College of Pharmacy's Research Day & Symposium

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that its Director of Biology, Eva van Rooij, Ph.D., will give the keynote lecture at The Ohio State University College of Pharmacy’s Research Day & Symposium. The lecture, which is scheduled to take place this afternoon in the University’s Biomedical Research Tower, will center on miRNAs of interest to miRagen and the chemistries involved in their manipulation.